Thymic residual masses in adult patients with Non-Hodgkin's Lymphoma (NHL) and Hodgkin's Disease (HD).

被引：0
|
作者：
Tartas, N
Chacón, C
Domenichini, E
Pascuccelli, H
Sporn, V
Mazzucco, J
Korin, J
Barazzutti, L
Ferro, H
Busso, P
Foncuberta, C
Kusminsky, G
Chacón, R
Avalos, JS
机构：
[1] Alexander Fleming Inst, Buenos Aires, DF, Argentina
[2] CEH, Buenos Aires, DF, Argentina
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4348
引用
收藏
页码：255B / 255B
页数：1
相关论文
共 50 条
  • [1] Anticipation occurs in familial Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL).
    Wiernik, PH
    Wang, SQ
    Hu, XP
    Marino, P
    BLOOD, 1997, 90 (10) : 3964 - 3964
  • [2] Analysis of ploidy and proliferative activity in childhood non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD)
    Coad, NAG
    Jones, TJ
    Muir, KR
    Parkes, SE
    Smith, K
    Raafat, F
    Mann, JR
    PEDIATRIC PATHOLOGY & LABORATORY MEDICINE, 1997, 17 (06): : 893 - 902
  • [3] Standardized uptake value (SUV) for staging of non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD).
    Cortés-Blanco, A
    Martínez-Lázaro, R
    Zhuang, HM
    Alavi, AA
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 279P - 279P
  • [4] ASHAP salvage therapy for recurrent and refractory Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL).
    Hanel, M
    Hoffknecht, MM
    Peters, SO
    Fiedler, F
    Hanel, A
    Kruger, WH
    Zeller, W
    Braumann, D
    Illiger, HJ
    Metzner, B
    Schubert, JC
    Schmitz, N
    Weh, HJ
    Kroger, N
    Zander, AR
    BLOOD, 1997, 90 (10) : 4559 - 4559
  • [5] INCIDENCE AND FACTORS INFLUENCING STEM CELL MOBILIZATION IN PATIENTS WITH NON-HODGKIN'S LYMPHOMA (NHL) AND HODGKIN'S DISEASE (HD)
    Popat, U.
    Saliba, R.
    Ahlawat, S.
    Okoroji, G. J.
    Alousi, A.
    Anderlini, P.
    Andersson, B.
    de Lima, M.
    Jones, R.
    Kebriaei, P.
    Korbling, M.
    Nieto, Y.
    Qazilbash, M.
    Shpall, E. J.
    Khouri, I
    Giralt, S.
    Champlin, R.
    Hosing, C.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 37 - 38
  • [6] Clinical relevance of angiogenesis-modulating factors in patients with Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL).
    Giles, FJ
    Vose, JM
    Manshouri, T
    Dey, A
    Bociek, G
    Bierman, PJ
    Keating, M
    Armitage, JO
    Albitar, M
    BLOOD, 2001, 98 (11) : 805A - 805A
  • [7] Autologous transplants followed by mini-allografts for Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL).
    Carella, AM
    Corsetti, MT
    Lerma, E
    Cavaliere, M
    BLOOD, 2000, 96 (11) : 407A - 407A
  • [8] Follow-up (FU) policy after treatment for Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL); The patients view
    Watson, AJ
    Pool, C
    Radford, JA
    BRITISH JOURNAL OF CANCER, 1999, 80 : 20 - 20
  • [9] Phase II study of thalidomide in patients with recurrent Hodgkin's disease (HD) and non-Hodgkin's lymphomas (NHL).
    Pro, B
    Younes, A
    Albitar, M
    Hagemeister, FB
    Rodriguez, MA
    McLaughlin, P
    Clemons, M
    Samaniego, F
    Cabanillas, F
    BLOOD, 2001, 98 (11) : 246B - 246B
  • [10] Hodgkin's disease is a non-Hodgkin lymphoma
    Taylor, CR
    HUMAN PATHOLOGY, 2005, 36 (01) : 1 - 4
12345